Between Pathological Prostate Cancer Lymph Nodes and Sentinel Nodes: Which Information Is the Leader?
Agnès MorelThierry RousseauLudovic FerrerJacques LacostePierre NevouxElise Picot-DillyMaelle Le ThiecDaniela RusuLoic CampionCaroline RousseauPublished in: Clinical nuclear medicine (2024)
SLNB seems to contain decisive information for the clinical outcome of patients with localized intermediate- and high-risk prostate cancer patients. The question raised is thus whether immediate additional postoperative treatment should be offered to patients with metastatic SLN.